Joseph M. Herman

2000–2025 年に発表

148
論文数
24,905
被引用数
87
h 指数
143
i10 指数

被引用数

Joseph M. Herman の年別被引用数1986 年: 被引用 1 件2002 年: 被引用 1 件2003 年: 被引用 6 件2004 年: 被引用 11 件2005 年: 被引用 13 件2006 年: 被引用 11 件2007 年: 被引用 16 件2008 年: 被引用 27 件2009 年: 被引用 45 件2010 年: 被引用 43 件2011 年: 被引用 79 件2012 年: 被引用 126 件2013 年: 被引用 181 件2014 年: 被引用 226 件2015 年: 被引用 287 件2016 年: 被引用 302 件2017 年: 被引用 283 件2018 年: 被引用 281 件2019 年: 被引用 1,082 件2020 年: 被引用 1,210 件2021 年: 被引用 1,037 件2022 年: 被引用 696 件2023 年: 被引用 483 件2024 年: 被引用 777 件2025 年: 被引用 309 件2026 年: 被引用 5 件1987〜2001 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,524 件、この内訳の 27.4%中国: 引用元論文 1,271 件、この内訳の 13.8%ドイツ: 引用元論文 526 件、この内訳の 5.7%イタリア: 引用元論文 509 件、この内訳の 5.5%日本: 引用元論文 471 件、この内訳の 5.1%イギリス: 引用元論文 425 件、この内訳の 4.6%オランダ: 引用元論文 353 件、この内訳の 3.8%フランス: 引用元論文 327 件、この内訳の 3.6%カナダ: 引用元論文 285 件、この内訳の 3.1%韓国: 引用元論文 256 件、この内訳の 2.8%オーストラリア: 引用元論文 206 件、この内訳の 2.2%スペイン: 引用元論文 190 件、この内訳の 2.1%
0%27.4%その他 20.3%

分野

  • Medicine73%
  • Biochemistry, Genetics and Molecular Biology17.4%
  • Immunology and Microbiology2.3%
  • Physics and Astronomy1.8%
  • Environmental Science1.2%
  • Engineering1.1%
  • その他3.2%

トピック

  • Pancreatic and Hepatic Oncology Research16.2%
  • Cholangiocarcinoma and Gallbladder Cancer Studies4.4%
  • Cancer Genomics and Diagnostics3.8%
  • Pancreatitis Pathology and Treatment3.7%
  • Cancer Immunotherapy and Biomarkers2.5%
  • Cancer Cells and Metastasis2.2%
  • その他67.2%

共著者

全論文

検索で開く
  1. Pancreatic cancer

    著者: , , , , - The Lancet 2011 被引用: 2,596

  2. Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas

    著者: , , , , , , , , , , , , , , , , , - JAMA Oncology 2022 被引用: 281

  3. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah P. Thayer, Colin D. Weekes, Robert A. Wolff, Brian M. Wolpin, Jennifer L. Burns, Susan Darlow - Journal of the National Comprehensive Cancer Network 2017 被引用: 1,030

  4. Circulating Nucleic Acids Are Associated With Outcomes of Patients With Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 被引用: 371

  5. Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an international multidisciplinary working group

    著者: , , , , , , , , , , , , , - European Journal of Nuclear Medicine and Molecular Imaging 2022 被引用: 104

  6. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , - JCI Insight 2019 被引用: 172

  7. Vaccine-Induced Intratumoral Lymphoid Aggregates Correlate with Survival Following Treatment with a Neoadjuvant and Adjuvant Vaccine in Patients with Resectable Pancreatic Adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin He, Christopher L. Wolfgang, Elizabeth D. Thompson, Robert A. Anders, Elizabeth A. Sugar, Elizabeth M. Jaffee, Daniel A. Laheru - Clinical Cancer Research 2020 被引用: 77

  8. Pancreatic Cancer Patient-derived Organoids Can Predict Response to Neoadjuvant Chemotherapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Surgery 2022 被引用: 86

  9. DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 1,078

  10. Recent progress in pancreatic cancer

    著者: , , , , , , - CA A Cancer Journal for Clinicians 2013 被引用: 940

  11. Cadmium Exposure and Liver Disease among US Adults

    著者: , , , , , , , , - Journal of Gastrointestinal Surgery 2013 被引用: 281

  12. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giulia Martina Cavestro, Kari G. Chaffee, Charles C. Chung, Sean P. Cleary, Michelle Cotterchio, Frederike Dijk, Eric J. Duell, Lenka Foretová, Charles S. Fuchs, Niccola Funel, Steven Gallinger, J. Michael Gaziano, Maria Gazouli, Graham G. Giles, Edward Giovannucci, Michael Goggins, Gary E. Goodman, Phyllis J. Goodman, Thilo Hackert, Christopher A. Haiman, Patricia Hartge, Manal Hasan, Péter Hegyi, Kathy J. Helzlsouer, Joseph M. Herman, Ivana Holcátová, Elizabeth A. Holly, Robert N. Hoover, Rayjean J. Hung, Eric J. Jacobs, Krzysztof Jamroziak, Vladimí­r Janout, Rudolf Kaaks, Kay‐Tee Khaw, Eric A. Klein, Manolis Kogevinas, Charles Kooperberg, Matthew H. Kulke, Juozas Kupčinskas, Robert J. Kurtz, Daniel A. Laheru, Stefano Landi, Rita T. Lawlor, I.-Min Lee, Loı̈c Le Marchand, Lingeng Lu, Núria Malats, Andrea Mambrini, Satu Männistö, Roger L. Milne, Beatrice Mohelníková-Duchoňová, Rachel Ε. Neale, John P. Neoptolemos, Ann L. Oberg, Sara H. Olson, Irene Orlow, Claudio Pasquali, Alpa V. Patel, Ulrike Peters, Raffaele Pezzilli, Miquel Porta, Francisco X. Real, Nathaniel Rothman, Ghislaine Scélo, Howard D. Sesso, Gianluca Severi, Xiao‐Ou Shu, Debra T. Silverman, Jill P. Smith, Pavel Souček ほか 23 名 - Nature Communications 2018 被引用: 280

  13. Response and Survival Associated With First-line FOLFIRINOX vs Gemcitabine and nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal Adenocarcinoma

    著者: , , , , , , , , , , , , , , , - JAMA Surgery 2020 被引用: 179

  14. Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma

    著者: , , , , , , , , , , , , , - Journal of Gastrointestinal Surgery 2012 被引用: 550

  15. Phase 2 multi‐institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma

    著者: , , , , , , , , , , , , , , , , , , , - Cancer 2014 被引用: 538

  16. Survival in Patients With Severe Lymphopenia Following Treatment With Radiation and Chemotherapy for Newly Diagnosed Solid Tumors

    著者: , , , , , , , , - Journal of the National Comprehensive Cancer Network 2015 被引用: 322

  17. Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 378

  18. Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James B. Potash, Andrew D. Rhim, Alyssa Smith, Yuxuan Wang, Christopher L. Wolfgang, Laura D. Wood, Peter P. Zandi, Michael Goggins, Rachel Karchin, James R. Eshleman, Nickolas Papadopoulos, Kenneth W. Kinzler, Bert Vogelstein, Ralph H. Hruban, Alison P. Klein - Cancer Discovery 2015 被引用: 366

  19. Emergence of Stereotactic Body Radiation Therapy and Its Impact on Current and Future Clinical Practice

    著者: , , - Journal of Clinical Oncology 2014 被引用: 248

  20. Clinical Significance of the Genetic Landscape of Pancreatic Cancer and Implications for Identification of Potential Long-term Survivors

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2012 被引用: 276

  21. Lymphocyte-Sparing Effect of Stereotactic Body Radiation Therapy in Patients With Unresectable Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2015 被引用: 231

  22. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joseph M. Herman, Ivana Holcátová, Elizabeth A. Holly, Robert N. Hoover, Rayjean J Hung, Vladimí­r Janout, Timothy J. Key, Juozas Kupčinskas, Robert C. Kurtz, Stefano Landi, Lingeng Lu, Ewa Małecka‐Panas, Andrea Mambrini, Beatrice Mohelníková-Duchoňová, John P. Neoptolemos, Ann L. Oberg, Irene Orlow, Claudio Pasquali, Raffaele Pezzilli, Cosmeri Rizzato, Amethyst Saldia, Aldo Scarpa, Rachael Z. Stolzenberg‐Solomon, Oliver Strobel, Francesca Tavano, Yogesh K. Vashist, Pavel Vodička, Brian M. Wolpin, Herbert Yu, Gloria M. Petersen, Harvey A. Risch, Alison P. Klein - Nature Genetics 2015 被引用: 270

  23. Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sarah E. Hoffe - The Lancet Oncology 2023 被引用: 33

  24. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - JAMA Surgery 2016 被引用: 449